Inotiv, inc. announces closing of $125 million convertible senior notes offering and full exercise of option to purchase additional $15 million of notes

West lafayette, ind., sept. 27, 2021 (globe newswire) -- inotiv, inc. (nasdaq:notv) (the “company”, “we”, “our” or “inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, today announced the closing of its offering of $140,000,000 aggregate principal amount of 3.25% convertible senior notes due 2027 (the “notes”), including $15,000,000 of additional notes, in a private offering to qualified institutional buyers pursuant to rule 144a under the securities act of 1933, as amended (the “securities act”). the company's obligations under the notes are guaranteed by bas evansville, inc., a wholly owned subsidiary of the company.
NOTV Ratings Summary
NOTV Quant Ranking